@article{rodwin:inserm-03338243,
  TITLE = {{The use of ‘added benefit' to determine the price of new anti-cancer drugs in France, 2004--2017}},
  AUTHOR = {Rodwin, Marc A and Mancini, Julien and Duran, S{\'e}gol{\`e}ne and Jalbert, Anne-C{\'e}line and Viens, Patrice and Maraninchi, Dominique and Gon{\c c}alves, Anthony and Marino, Patricia},
  URL = {https://inserm.hal.science/inserm-03338243},
  JOURNAL = {{European Journal of Cancer}},
  PUBLISHER = {{Elsevier}},
  VOLUME = {145},
  PAGES = {11 - 18},
  YEAR = {2021},
  MONTH = Mar,
  DOI = {10.1016/j.ejca.2020.11.031},
  KEYWORDS = {Clinical added benefit ; Drugs ; Oncology ; Price ; Value},
  PDF = {https://inserm.hal.science/inserm-03338243/file/PIIS0959804921002495.pdf},
  HAL_ID = {inserm-03338243},
  HAL_VERSION = {v1},
}